1.94

6.01% 0.11

Neuroone Medical Technologies Corp (NMTC)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Neuroone Medical Technologies Corp stock is traded at $1.94, with a volume of 94,069. It is up +6.01% in the last 24 hours and down -20.16% over the past month. NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Previous Close:

$1.83

Open:

$1.9

24h Volume:

94,069

Relative Volume:

1.89

Market Cap:

$16.88M

Revenue:

$9.19M

Net Income/Loss:

$-6.94M

P/E Ratio:

-2.3326

EPS:

-0.8317

Net Cash Flow:

$-7.57M

1W Performance:

+19.02%

1M Performance:

-20.16%

6M Performance:

-60.24%

1Y Performance:

-61.04%

1-Day Range:

$1.75

$2.04

1-Week Range:

$1.46

$2.04

52-Week Range:

$1.4231

$6.96

Neuroone Medical Technologies Corp Stock (NMTC) Company Profile

Name

Neuroone Medical Technologies Corp

Sector

Healthcare (1080)

Industry

Medical Devices (141)

Phone

(952) 426-1383

Address

7599 ANAGRAM DR, EDEN PRAIRIE

Employee

Twitter

Next Earnings Date

2026-08-13

Latest SEC Filings

NMTC's Discussions on Twitter

Compare NMTC vs MOBBW, PSNYW, GOODO, SHMD, DWLD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NMTC	0.99	0	0	0	0	0.00
MOBBW Mobilicom Limited Warrants	1.86	2.83B	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	2.89	388.34M	2.07B	-1.42B	-1.37B	-0.6765
GOODO Gladstone Commercial Corporation	20.88	372.90M	0	0	0	0.00
SHMD Schmid Group N V	5.45	348.74M	52.15M	-21.46M	0	-0.4675
DWLD Davis Select Worldwide ETF	48.03	0	0	0	0	0.00

Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-05-25	Initiated	Ladenburg Thalmann	Buy
Mar-29-22	Downgrade	Craig Hallum	Buy → Hold

Neuroone Medical Technologies Corp Stock (NMTC) Latest News

Aug 14, 2026

NMTC Maintained by Maxim Group -- Price Target Lowered to $5.00 - GuruFocus

Aug 14, 2026

Aug 13, 2026

NeuroOne Medical Technologies Corporation Q3 2026 Earnings Call Summary - Yahoo Finance

Aug 13, 2026

Earnings call transcript: NeuroOne Medical posts Q3 2026 revenue growth as shares fall - Investing.com

Aug 13, 2026

Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com Australia

Aug 13, 2026

Is NeuroOne Medical Technologies Corp (NMTC) Positioned for Grow - GuruFocus

Aug 13, 2026

NEUROONE MEDICAL TECHNOLOGIES Corp 3Q FY2026: Revenue $1.97M, EPS $(0.28) — 10-Q Summary - TradingView

Aug 13, 2026

Q3 2026 NeuroOne Medical Technologies Corp Earnings Call Transcript - GuruFocus

Aug 13, 2026

NeuroOne posts Q3 FY2026 revenue up 16% to $2.0M; gross margin expands to 59.9% - TradingView

Aug 13, 2026

NeuroOne Medical Technologies (NASDAQ: NMTC) posts larger loss and flags going concern risk - Stock Titan

Aug 13, 2026

NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9% - Yahoo Finance

Aug 13, 2026

Aug 11, 2026

NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification - Yahoo Finance

Aug 11, 2026

Aug 06, 2026

Calendrier des fractionnements d'actions pour: - Yahoo Finance France

Aug 06, 2026

Aug 03, 2026

NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time - Yahoo Finance

Aug 03, 2026

Jul 31, 2026

NeuroOne Medical Technologies Corp - TradingKey

Jul 31, 2026

Jul 30, 2026

NeuroOne Releases CNS Drug Delivery White Paper Ahead of Planned Fiscal Year-End Availability of the StereoCED(TM) Platform - Yahoo Finance

Jul 30, 2026

Jul 28, 2026

NeuroOne(R) Highlights Potential Paradigm Shift for Patients Treated With the OneRF(R) Brain Ablation System Based on Reports by Physicians - Yahoo Finance

Jul 28, 2026

Jul 27, 2026